3D screen printing provides innovative drug development capabilities that are difficult or...
Author - David Miller
Overcoming Pharma Marketing Challenges with AI
Ted Sweetser discusses how the technology is providing greater insight into how marketing materials...
Industry Outlook 2025: Technology as a Supporting Element
Pharmaceutical Technology® spoke with Alexander Seyf, CEO and co-founder of Autolomous, about the...
Potential Synergy Between Obesity and Myopathies
Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics, explores the potential synergy...
Bayer Announces FDA’s First Full Approval of NTRK Inhibitor
Vitrakvi (larotrectinib) was first granted accelerated approval by FDA in November 2018.
A behind-the-scenes look at the 2025 Breakthrough West agenda...
A behind-the-scenes look at this year’s agenda Dear readers: You come to STAT for tough, smart...
Milan Kalawadia: Carving Out New Pathways
Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new...
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for...
On April 14, 2025, the Trump Administration launched a national security-driven investigation into...
‘Earning’ Power
The job of pharma-driven messaging and reputation management may never be more important than it is...
STAT+: Biotech entrepreneur Sam Waksal accused of ‘reckless...
Sam Waksal is once again in legal trouble. The biotech entrepreneur, who was famously convicted...